Oculis Holding AG - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
OCS Nasdaq 2830 oculis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oculis Holding AG

Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis - Oct 22nd, 2026 12:00 am
Oculis Reports New Phase 2 ACUITY Biomarker Data  Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis - Oct 22nd, 2026 12:00 am
Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting - Oct 20th, 2026 12:00 am
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease - Oct 19th, 2026 12:00 am
Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki - Oct 19th, 2026 12:00 am
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day - Oct 7th, 2026 12:00 am
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS - Oct 1st, 2026 12:00 am
Oculis Announces Resignation of Lionel Carnot from Board of Directors - Sep 30th, 2026 2:46 pm
After Plunging 24% in 4 Weeks, Here's Why the Trend Might Reverse for Oculis Holding AG (OCS) - Sep 28th, 2026 6:35 am
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength? - Sep 23rd, 2026 3:30 am
Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade - Aug 31st, 2026 7:55 am
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis - Aug 24th, 2026 2:00 am
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - Aug 14th, 2026 2:05 pm
Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect? - Aug 14th, 2026 7:55 am
Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - Aug 10th, 2026 2:45 am